Ioannis Oikonomou to Adult
This is a "connection" page, showing publications Ioannis Oikonomou has written about Adult.
Connection Strength
0.118
-
Are we moving forward in the biological treatment of Crohn's disease? Time will tell. Inflamm Bowel Dis. 2006 Feb; 12(2):147-9.
Score: 0.028
-
Anti-a4?7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. Sci Transl Med. 2018 10 03; 10(461).
Score: 0.017
-
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study. Inflamm Bowel Dis. 2015 Aug; 21(8):1809-16.
Score: 0.013
-
The inflammatory bowel disease live interinstitutional and interdisciplinary videoconference education (IBD LIVE) series. Inflamm Bowel Dis. 2014 Oct; 20(10):1687-95.
Score: 0.013
-
Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients. Inflamm Bowel Dis. 2014 Mar; 20(3):525-33.
Score: 0.012
-
The influence of depression on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jul; 19(8):1732-9.
Score: 0.012
-
Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis. Am J Gastroenterol. 2009 Mar; 104(3):639-46.
Score: 0.009
-
Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum. 2007 Apr; 50(4):498-508.
Score: 0.008
-
Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch. Am J Gastroenterol. 2006 Dec; 101(12):2760-8.
Score: 0.007